Citation Impact
Citing Papers
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
2005 Standout
Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
2012
EGFR Antagonists in Cancer Treatment
2008 Standout
Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells
2006
Comparison Between Genetic Portraits of Osteoblasts Derived From Primary Cultures and Osteoblasts Obtained From Human Pulpar Stem Cells
2008
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives
2010 StandoutNobel
Src family kinases in tumor progression and metastasis
2003
Platycodin D induces anoikis and caspase‐mediated apoptosis via p38 MAPK in AGS human gastric cancer cells
2012
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
Cancer drug resistance: an evolving paradigm
2013 Standout
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
2011 Standout
Cell-Cell Contacts Prevent Anoikis in Primary Human Colonic Epithelial Cells
2006
The interplay between Src and integrins in normal and tumor biology
2004
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
2006
Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades
2003
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 Standout
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
2011
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
A renaissance for SRC
2004
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
2009 StandoutNature
Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice
2004
The MAPK pathway across different malignancies: A new perspective
2014 Standout
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
2005
Active participation of endothelial cells in inflammation
2005
SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models
2005
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine
2009 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
2008
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Cancer Genome Landscapes
2013 StandoutScience
Works of T. Christopher Windham being referenced
Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers
2002
Src activation regulates anoikis in human colon tumor cell lines
2002